Novan Expands Nitric Oxide Dermatology Business Partnership with Sato in Japan
Expanded license agreement adds SB206 for the treatment of viral skin infections Novan to receive upfront cash consideration of approximately 1.25 billion JPY (~$11.0 million), payable over the next 12 months Milestone and royalty payments due with …